Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 30.26 Million

CAGR (2025-2030)

4.05%

Fastest Growing Segment

Software

Largest Market

     Northern & Central

Market Size (2030)

USD 37.96 Million


Market Overview

Saudi Arabia AI in Medical Diagnostics Market was valued at USD 30.26 Million in 2024 and is expected to reach USD 37.96 Million by 2030 with a CAGR of 4.05% during the forecast period. The Saudi Arabian AI in medical diagnostics market is witnessing remarkable growth, driven by the country's ambitious vision for healthcare modernization. As the Kingdom increasingly invests in advanced technologies to transform its healthcare infrastructure, artificial intelligence (AI) is playing a crucial role in reshaping diagnostic capabilities. The recent findings indicate a favorable view of AI in healthcare among respondents in Saudi Arabia, with many disagreeing that AI diminishes the value of the medical profession. Additionally, half of the respondents either agreed or strongly agreed that AI contributes to reducing errors in medical practice. The integration of AI in medical diagnostics is enhancing the accuracy, speed, and efficiency of disease detection and treatment, contributing to improved patient outcomes.

One of the key drivers of this market is the government's commitment to digital healthcare transformation, as outlined in Saudi Vision 2030. This initiative aims to diversify the economy and modernize various sectors, including healthcare. AI-driven diagnostic tools are helping healthcare professionals in the Kingdom to diagnose complex diseases such as cancer, cardiovascular conditions, and neurological disorders with greater precision. The technology enables earlier detection, reducing the burden on healthcare systems and improving the chances of successful treatment.

Despite the promising outlook, challenges remain. High implementation costs and the need for skilled personnel to manage AI systems are potential barriers to widespread adoption. However, as technology becomes more accessible and the workforce more adept at utilizing AI tools, these challenges are expected to diminish.

Key Market Drivers

Growth in Healthcare Industry

The growth of the healthcare industry in Saudi Arabia is emerging as a significant driver of the AI in medical diagnostics market. The health law in Saudi Arabia is designed to ensure equitable and accessible healthcare for all citizens. The Ministry of Health (MoH) oversees an integrated network of healthcare services that spans all regions of the country. Public healthcare services are provided free of charge to Saudi citizens, following a new health strategy tailored to the sector's evolving needs. In collaboration with regional councils, the MoH assesses the demand, locations, and levels of healthcare provision, taking into account geographic and demographic factors, as well as regional disease patterns. It is important to note that healthcare in public medical facilities remains free for citizens, in alignment with the strategic plan designed to address the sector's requirements.

As the Kingdom advances its healthcare infrastructure in line with Vision 2030, there has been a sharp increase in demand for innovative technologies to enhance diagnostic accuracy and efficiency. The expanding healthcare sector, fueled by increasing investments in hospitals, clinics, and specialized care centers, is creating a conducive environment for the adoption of artificial intelligence in diagnostics.

AI-powered diagnostics offer faster and more precise interpretations of medical imaging and pathology reports, reducing human error and improving patient outcomes. With a growing number of medical facilities and rising patient numbers, the need for efficient diagnostic tools has become more apparent. Moreover, the integration of AI technology in healthcare aligns with the government’s focus on modernizing the sector and improving accessibility to advanced medical services.

The expansion of the healthcare sector is also encouraging collaborations between healthcare providers and technology companies, accelerating the development and implementation of AI solutions. These collaborations are not only fostering innovation but are also ensuring that AI-driven diagnostics become a core part of the healthcare system in Saudi Arabia. As the healthcare industry continues to grow, the adoption of AI in medical diagnostics is expected to rise significantly, further driving market growth.

Surge in Technological Advancements

The surge in technological advancements is playing a pivotal role in driving the growth of Saudi Arabia's AI in medical diagnostics market. In Saudi Arabia, King Faisal Specialist Hospital and Research Center has introduced an AI-driven system for mammogram analysis, enhancing radiologists' ability to detect breast cancer with greater accuracy. Additionally, partnerships between the Ministry of Health and technology leaders like IBM focus on developing AI tools to facilitate the early diagnosis of chronic diseases, including cardiovascular conditions and diabetes. With the rapid adoption of cutting-edge innovations such as machine learning, natural language processing, and deep learning algorithms, healthcare providers in the Kingdom are increasingly integrating AI tools to enhance diagnostic accuracy and efficiency. These technologies allow for faster, more precise interpretation of medical data, including imaging, pathology, and genomics, significantly improving patient outcomes.

Moreover, the government’s commitment to digital transformation in line with Saudi Vision 2030 has spurred investments in AI-powered healthcare solutions. This strategic focus is fostering collaborations between local healthcare institutions, tech startups, and international AI companies, accelerating the development and deployment of advanced diagnostic systems. The ability of AI to analyze vast amounts of medical data and detect patterns that may elude human clinicians is reducing diagnostic errors, optimizing treatment plans, and increasing operational efficiency in hospitals.

Additionally, advancements in cloud computing and data infrastructure are enabling seamless integration of AI systems across healthcare networks, providing real-time access to critical patient data. These innovations not only enhance clinical decision-making but also contribute to the scalability of AI-driven diagnostics, addressing the growing demand for healthcare services in Saudi Arabia’s expanding population.


Saudi Arabia AI in Medical Diagnostics Market


Download Free Sample Report

Key Market Challenges

Lack of Skilled Professionals

One of the significant challenges hindering the growth of Saudi Arabia's AI in medical diagnostics market is the shortage of skilled professionals capable of managing and operating AI-driven technologies. While the country is making significant strides in healthcare innovation, the deployment of advanced AI systems requires a specialized workforce with expertise in both healthcare and data science—a resource that remains in short supply.

The integration of AI into medical diagnostics demands professionals who are not only proficient in handling AI algorithms and machine learning models but also possess a deep understanding of clinical practices. This combination of skills is essential to ensure the effective application of AI tools in areas such as medical imaging, pathology, and patient data analysis. Currently, there is a gap between the rapid technological advancements and the availability of qualified personnel trained to harness the full potential of these innovations.

This shortage is compounded by the limited AI-focused education and training programs within the country, particularly those tailored to the healthcare sector. While universities and educational institutions are beginning to introduce AI-related courses, the pace of workforce development has yet to catch up with the demand for skilled professionals in the field. As a result, healthcare providers often face challenges in fully adopting AI diagnostic tools, limiting their ability to leverage these technologies for improved patient outcomes.

Key Market Trends

AI in Radiology and Imaging

AI in radiology and imaging is emerging as a pivotal trend in Saudi Arabia's AI in medical diagnostics market. In Saudi Arabia, aligning with the research findings of 2024, Qurashi et al. observed that a significant proportion of radiology professionals (83%) reported familiarity with machine learning and AI concepts. However, only a small percentage (18%) had practical experience with AI, attributing this gap to the absence of formal training within the curriculum. The rapid integration of artificial intelligence into radiological practices is revolutionizing the way medical imaging is conducted and analyzed, offering enhanced precision, speed, and efficiency. With the increasing demand for high-quality diagnostic services and the growing volume of radiological data, AI is being leveraged to streamline processes, reduce human error, and improve diagnostic accuracy.

AI algorithms, particularly in areas such as image recognition and analysis, are now capable of detecting subtle abnormalities in medical images, including X-rays, CT scans, MRIs, and ultrasounds, with unprecedented speed and precision. This technological advancement is particularly beneficial in Saudi Arabia's healthcare sector, where there is a need to address the rising prevalence of chronic diseases such as cardiovascular conditions and cancer, which rely heavily on accurate imaging for early diagnosis.

Additionally, AI in radiology enables the automation of routine tasks, allowing radiologists to focus on more complex cases and improving overall workflow efficiency. The growing adoption of AI in imaging is also driving collaborations between healthcare providers and tech firms, aiming to develop more sophisticated diagnostic tools. This trend is expected to grow as healthcare facilities in Saudi Arabia continue to modernize, further driving the AI in medical diagnostics market forward.

Segmental Insights

Component Insights

Based on Component, Software have emerged as the fastest growing segment in the Saudi Arabia AI in Medical Diagnostics Market in 2024. The increasing reliance on software-based AI solutions in healthcare systems is transforming how medical data is processed, analyzed, and interpreted. Software applications powered by artificial intelligence, such as diagnostic imaging tools, predictive analytics, and decision-support systems, offer healthcare professionals more accurate, efficient, and scalable solutions compared to traditional methods.

One of the key drivers of this growth is the enhanced diagnostic capabilities that AI software provides. Through machine learning algorithms, software can analyze vast datasets from medical imaging, electronic health records, and genomic data to identify patterns, anomalies, and disease indicators with remarkable precision. This capability significantly reduces human error, shortens diagnosis times, and improves patient care outcomes.

Application Insights

Based on Application, Oncology have emerged as the fastest growing segment in the Saudi Arabia AI in Medical Diagnostics Market during the forecast period. The increasing prevalence of cancer in Saudi Arabia, driven by lifestyle changes and an aging population, has heightened the demand for advanced diagnostic tools. AI technologies enable early detection, personalized treatment plans, and improved patient outcomes, making oncology a critical area of focus for healthcare providers.

AI-driven diagnostic tools, such as machine learning algorithms and imaging technologies, have proven to be highly effective in detecting various types of cancer, including breast, lung, and prostate cancers. These technologies enhance the accuracy of diagnoses, reduce human error, and improve the speed of detecting malignancies, which is vital in oncology.


 Saudi Arabia AI in Medical Diagnostics Market


Download Free Sample Report

Regional Insights

Based on Region, Northern & Central have emerged as the dominating region in the Saudi Arabia AI in Medical Diagnostics Market in 2024. The Northern and Central regions, particularly Riyadh, the capital city, house the majority of Saudi Arabia’s advanced healthcare facilities, hospitals, and research institutions. These regions have become hubs for healthcare innovation and are pivotal in the adoption of AI technologies, as they host a high concentration of medical professionals and institutions eager to implement cutting-edge diagnostic tools.

The Saudi government has made substantial investments in healthcare infrastructure within these regions, aligning with Vision 2030’s objectives to modernize healthcare through digital technologies, including AI. The government's focus on developing high-tech healthcare ecosystems in Riyadh and surrounding areas has accelerated the adoption of AI-based diagnostic solutions, making it the key region for growth.

Recent Development

  • In November 2024, Magrabi Health formed a strategic partnership with Digital Diagnostics and Tamer Healthcare to introduce LumineticsCore, an AI-driven system for detecting diabetic retinopathy, at its Eye Hospital in Riyadh. Developed by Digital Diagnostics, LumineticsCore is the first autonomous AI system approved by both the FDA and SFDA for diagnosing this primary cause of vision loss. This collaboration supports Magrabi Health's rebranding strategy and aligns with Saudi Vision 2030’s emphasis on healthcare digital transformation. With over 7 million individuals affected by diabetes in Saudi Arabia, the technology aims to enhance patient outcomes through early detection and timely treatment. Tamer Healthcare contributes its expertise in healthcare products and services to further elevate accessibility and innovation in the sector.
  • In 2024, King Abdullah University of Science and Technology, in partnership with the Saudi Data and Artificial Intelligence Authority, introduced MiniGPT-Med, an advanced AI model with vision interface capabilities. This innovative tool is designed to enhance the precision of medical diagnostics by combining image analysis with textual clinical data, thereby significantly improving the detection of conditions such as pneumonia, edema, brain tumors, and lung cancer.
  • In November 2024, Diagnostics Elite Company, a leading provider of teleradiology services in Saudi Arabia and the Gulf region, announced the launch of DePACS - Butterfly. This advanced Picture Archiving and Communication System (PACS) is the first of its kind in Saudi Arabia, integrating artificial intelligence technology to improve efficiency and precision in healthcare. The high-capacity system is designed to process various types of medical images, including teleradiology as well as cell and tissue images. Key features of the system include AI-driven analysis tools, rapid communication with cloud storage servers, support for neutral archiving, and robust data protection protocols, offering healthcare professionals a secure and comprehensive solution.
  • In October 2024, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia implemented advanced artificial intelligence (AI) and robotics to enhance diagnostic precision, optimize patient care, and improve treatment outcomes. At the core of this initiative is the Centre for Healthcare Intelligence (CHI), which employs 20 AI applications to advance medical imaging, streamline patient flow, and improve resource management, promoting a sustainable AI ecosystem. By utilizing predictive models for bone marrow transplants and heart failure readmissions, CHI enables the early identification of high-risk patients, facilitating personalized, real-time treatment interventions. In partnership with the Saudi Commission for Health Specialties, CHI has also introduced a training program in applied health AI, equipping healthcare professionals with the skills to make accurate and timely decisions.

Key Market Players

  • Alphabet Inc.
  • NVIDIA Corporation
  • Saudi Company for Artificial Intelligence (SCAI)
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.

By Component

By Application

By Region

  • Software
  • Services
  • Hardware
  • Oncology
  • Neurology
  • Cardiology
  • Radiology
  • Pulmonology
  • Obstetrics/Gynecology
  • Others
  • Eastern
  • Western
  • Northern & Central
  • Southern

Report Scope

In this report, the Saudi Arabia AI in Medical Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Saudi Arabia AI in Medical Diagnostics Market, By Component:

o   Software

o   Services

o   Hardware

  • Saudi Arabia AI in Medical Diagnostics Market, By Application:

o   Oncology

o   Neurology

o   Cardiology

o   Radiology

o   Pulmonology

o   Obstetrics/Gynecology

o   Others

  • Saudi Arabia AI in Medical Diagnostics Market, By Region:

o   Eastern

o   Western

o   Northern & Central

o   Southern

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia AI in Medical Diagnostics Market.

Available Customizations:

Saudi Arabia AI in Medical Diagnostics Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Saudi Arabia AI in Medical Diagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Saudi Arabia AI in Medical Diagnostics Market Outlook

4.1.  Market Size & Forecast

4.1.1. By Value

4.2.  Market Share & Forecast

4.2.1.      By Component (Software, Services, Hardware)

4.2.2. By Application (Oncology, Neurology, Cardiology, Radiology, Pulmonology, Obstetrics/Gynecology, Others)

4.2.3. By Region

4.2.4. By Company

4.3.  Market Map

4.3.1. By Component

4.3.2. By Application

4.3.3. By Region

5.    Eastern AI in Medical Diagnostics Market Outlook

5.1.  Market Size & Forecast          

5.1.1. By Value

5.2.  Market Share & Forecast

5.2.1. By Component

5.2.2. By Application

6.    Western AI in Medical Diagnostics Market Outlook

6.1.  Market Size & Forecast          

6.1.1. By Value

6.2.  Market Share & Forecast

6.2.1. By Component

6.2.2. By Application

7.    Northern & Central AI in Medical Diagnostics Market Outlook

7.1.  Market Size & Forecast          

7.1.1. By Value

7.2.  Market Share & Forecast

7.2.1. By Component

7.2.2. By Application

8.    Southern AI in Medical Diagnostics Market Outlook

8.1.  Market Size & Forecast          

8.1.1. By Value

8.2.  Market Share & Forecast

8.2.1. By Component

8.2.2. By Application

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

10.1.              Recent Developments

10.2.              Product Launches

10.3.              Mergers & Acquisitions

11.  Policy & Regulatory Landscape

12.  Saudi Arabia Economic Profile

13.  Competitive Landscape

13.1.                Alphabet Inc.

13.1.1.  Business Overview

13.1.2.  Company Snapshot

13.1.3.  Products & Services

13.1.4.  Financials (In case of listed)

13.1.5.  Recent Developments

13.1.6.  SWOT Analysis

13.2.              NVIDIA Corporation

13.3.              Saudi Company for Artificial Intelligence (SCAI)

13.4.              Koninklijke Philips N.V.

13.5.              GE HealthCare Technologies Inc.

14.  Strategic Recommendations

About us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Saudi Arabia AI in Medical Diagnostics Market was estimated to be USD 30.26 Million in 2024.

The oncology segment demonstrated significant growth in 2024. This can be attributed to the high potential of personalized medicine in oncology.

Northern & Central dominated the market with a revenue share in 2024. This can be attributed to the high population density and demand for healthcare.

Growth in healthcare industry and surge in technological advancements are the major drivers for the Saudi Arabia AI in Medical Diagnostics Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.